SCHEMBL20544692

SCHEMBL20544692

COS(=O)(=O)[O-].C[n+]1cccc(CO)c1

nearest known ligand 0.44

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.37
CHRM1 known ✓ P11229 1/20 0.34
CHRM3 known ✓ P20309 1/20 0.34
LMNA P02545 3/20 0.44
FDPS P14324 1/20 0.43
USP2 O75604 1/20 0.42
NNMT P40261 1/20 0.39
CYP2C19 P33261 1/20 0.38
BCHE P06276 3/20 0.37
GLA P06280 2/20 0.37
TSHR P16473 2/20 0.37
MAPK1 P28482 1/20 0.37
HDAC8 Q9BY41 4/20 0.36
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11191706 0.84
SCHEMBL20544622 0.83 LMNA (0.41) LMNAFDPSUSP2NNMTCYP2C19
Iodide SCHEMBL4221259 0.82 FDPS (0.49) LMNAFDPSUSP2NNMTCYP2C19
SCHEMBL11689059 0.77 USP2 (0.42) LMNAUSP2NNMTBCHEGLA
SCHEMBL23004446 0.77 FUT7 (0.47) LMNACA2
SCHEMBL20544415 0.76 BCHE (0.37) LMNAFDPSUSP2NNMTBCHE
SCHEMBL20544696 0.76 USP2 (0.41) LMNAUSP2NNMTBCHEGLA
SCHEMBL11692088 0.76 HDAC8 (0.68) LMNAUSP2NNMTBCHEGLA
Trigonelline SCHEMBL11786615 0.75 USP2 (0.57) LMNAUSP2NNMTBCHEGLA
SCHEMBL2779790 0.73 HDAC8 (0.49) LMNAUSP2NNMTBCHEGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12398104-B2 Odorless thiols for permanent waving, straightening and depilatory applications THE PROCTER & GAMBLE COMPANY (US) 2025-08-26 US disclosed
CN-110573137-B Odorless thiols for permanent wave, straightening and dehairing applications 宝洁公司 2023-08-18 CN disclosed
EP-3614999-B1 ODORLESS THIOLS FOR PERMANENT WAVING, STRAIGHTENING AND DEPILATORY APPLICATIONS PROCTER & GAMBLE (US) 2022-07-13 EP disclosed
CN-110573137-A Odorless thiols for long lasting wave, straightening and depilatory applications 宝洁公司 2019-12-13 CN disclosed
US-20180311134-A1 ODORLESS THIOLS FOR PERMANENT WAVING, STRAIGHTENING AND DEPILATORY APPLICATIONS THE PROCTER & GAMBLE COMPANY 2018-11-01 US disclosed
US-20180312468-A1 ODORLESS THIOLS FOR PERMANENT WAVING, STRAIGHTENING AND DEPILATORY APPLICATIONS THE PROCTER & GAMBLE COMPANY 2018-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180312468-A1 ODORLESS THIOLS FOR PERMANENT WAVING, STRAIGHTENING AND DEPILATORY APPLICATIONS TST, TMT1A, PTMS ACHE 594/4885CHRM1 3085/4885CHRM3 2899/4885
US-12398104-B2 Odorless thiols for permanent waving, straightening and depilatory applications TST, TMT1A, PTMS ACHE 594/4885CHRM1 3085/4885CHRM3 2899/4885
US-20180311134-A1 ODORLESS THIOLS FOR PERMANENT WAVING, STRAIGHTENING AND DEPILATORY APPLICATIONS PLPBP, DAO, TST ACHE 2760/4885CHRM1 2861/4885CHRM3 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.